Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants
- 31 October 2004
- journal article
- Published by Elsevier in Virus Research
- Vol. 105 (2) , 183-194
- https://doi.org/10.1016/j.virusres.2004.05.009
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Host cell-mediated variation in H3N2 influenza virusesPublished by Elsevier ,2004
- Two Aromatic Residues in the PB2 Subunit of Influenza A RNA Polymerase Are Crucial for Cap BindingJournal of Biological Chemistry, 2003
- Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted a/ann arbor/6/60Virology, 2003
- Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineThe Journal of Pediatrics, 2000
- Influenza Immunization for ChildrenNew England Journal of Medicine, 1998
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998
- Emerging Infections: Pandemic InfluenzaEpidemiologic Reviews, 1996
- A Randomized Controlled Trial of Cold-Adapted and Inactivated Vaccines for the Prevention of Influenza A DiseaseThe Journal of Infectious Diseases, 1994
- Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trialVaccine, 1986
- INFLUENZAVIRUS INFECTIONS IN SEATTLE FAMILIES, 1975–1979American Journal of Epidemiology, 1982